Business Context and Reporting Period
This Form 8-K reports on the 2021 Annual Meeting of Stockholders held by IDEAYA Biosciences, Inc. on June 10, 2021. The filing details the voting results for director elections and the ratification of the independent auditor.
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
No material financial changes are reported in this filing. The document focuses solely on the outcomes of stockholder votes.
Guidance, Outlook, and Management Commentary
The filing contains no management commentary, financial guidance, or discussion of risks and contingencies. It strictly reports the tabulation of votes for two proposals:
- Proposal 1: Election of three Class II directors (Timothy M. Shannon, M.D.; Terry J. Rosen, Ph.D.; Wendy L. Yarno). All nominees received majority support.
- Proposal 2: Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the year ending December 31, 2021. The proposal was approved with 28,419,520 votes for, 9,530 against, and 23 abstentions.
Important Facts for Investors to Verify
- Shareholder Base: As of the record date (April 16, 2021), 32,905,592 shares of common stock were outstanding and entitled to vote.
- Director Election Results: Significant broker non-votes (2,678,718) were recorded for the director election, though all nominees were elected.
- Auditor Ratification: Stockholders overwhelmingly approved the selection of PricewaterhouseCoopers LLP.
- Emerging Growth Company Status: The registrant is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.